benefits of glp-1 coverage in corporate wellness Employers Take a Variety Approaches to The Growing Demand For GLP-1

Treatment for gastroparesis is challenging, and widely available therapies are often limited either by their poor evidence for efficacy or concerns over their long-term safety profile

Recent studies have shown increasing cases involving gastrointestinal problems linked to glucagon-like peptide-1 (GLP-1) receptor agonists.

However, GLP-1s may cause more serious side effects in older adults.

Backed by Science

Female albino Fischer rats were divided into four groups: untreated control animals (C), untreated diabetic animals (D), diabetic animals treated with QV formulation (DQV), and diabetic animals treated with insulin (DI)

Learn how medically supervised weight loss with GLP-1 therapy at Lorton Medical Spa can support effective appetite control, sustainable fat reduction, and healthier outcomes using evidence-based treatments.